10.09.2020 Drägerwerk AG & Co. KGaA  DE0005550602

DGAP-Adhoc: Drägerwerk AG & Co. KGaA: Dräger agrees with the federal government to end the delivery of ventilators


 

DGAP-Ad-hoc: Drägerwerk AG & Co. KGaA / Key word(s): Agreement
Drägerwerk AG & Co. KGaA: Dräger agrees with the federal government to end the delivery of ventilators

10-Sep-2020 / 16:28 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


Ad-hoc notification in accordance with Sec. 17 of the MAR

Drägerwerk AG & Co. KGaA: Dräger agrees with the federal government to end the delivery of ventilators

In March, Dräger received a major order from the federal government for the delivery of 10,000 ventilators. Thereby, the federal government ensured sufficient supply for the health care system in Germany in times of great uncertainty due to COVID-19. Since the beginning of the pandemic, Dräger has been in close contact with the federal government and many other customers around the world. Considering the current status of the development of the pandemic in Germany and other countries, Dräger and the federal government have now agreed in principle that Dräger will not deliver any more devices to the federal government beyond the 1,557 already delivered. The federal government bears the costs incurred for providing and upholding the production capacity. The capacities that are now being freed up enable Dräger to supply other important markets outside Germany with ventilators that are still urgently needed there.
Dräger's guidance published on July 14th remains unchanged. Accordingly, Dräger expects currency-adjusted net sales growth of 14 to 22 percent for 2020. The EBIT margin is expected to be between 7.0 and 11.0 percent.

Drägerwerk AG & Co. KGaA
Moislinger Allee 53-55
23558 Lübeck, Deutschland
www.draeger.com

Investor Relations:
Thomas Fischler
Tel. +49 451 882-2685
[email protected]

Corporate Communications:
Melanie Kamann
Tel. +49 451 882-3998
[email protected]

Disclaimer
This ad hoc report contains statements on the future development of Dräger Group. These forward-looking statements are based on the current expectations, presumptions, and forecasts of the Executive Board as well as the information available to date. They were compiled to the best of the company's knowledge. Dräger does not provide any warranty nor assume any responsibility for the future developments and results described above. These are dependent on a number of factors. They entail various risks and contingencies outside of the company's influence and are based on assumptions which could prove to be incorrect. Dräger does not assume any responsibility for updating the forward-looking statements contained in this report. This does not infringe any legal stipulations on the adjustment of forecasts. Please go to Investor Relations / Definitions of financial indicators at www.draeger.com for information on alternative performance measures used.


10-Sep-2020 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: Drägerwerk AG & Co. KGaA
Moislinger Allee 53-55
23542 Lübeck
Germany
Phone: +49 (0)451 882-0
Fax: +49 (0)451 882-2080
E-mail: [email protected]
Internet: www.draeger.com
ISIN: DE0005550602, DE 000 555 063 6, DE 000 555 065 1, DE 000 555 067 7, DE 000 555 071 9
WKN: 555060, 555063 Vorzüge, 555065 Genussschein A, 555067 Genussschein K, 555071 Genussschein D
Indices: TecDAX
Listed: Regulated Market in Berlin, Dusseldorf, Frankfurt (Prime Standard), Hamburg, Hanover, Munich; Regulated Unofficial Market in Stuttgart, Tradegate Exchange
EQS News ID: 1130085

 
End of Announcement DGAP News Service

1130085  10-Sep-2020 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1130085&application_name=news&site_id=boersengefluester_html


Die wichtigsten Finanzdaten auf einen Blick
  2016 2017 2018 2019 2020 2021 2022e
Umsatzerlöse1 2.523,84 2.572,26 2.595,01 2.780,82 3.406,78 3.328,42 3.112,00
EBITDA1,2 222,70 240,00 147,91 193,71 521,07 421,00 220,00
EBITDA-Marge3 8,82 9,33 5,70 6,97 15,30 12,65 7,07
EBIT1,4 136,91 155,74 62,65 66,58 396,60 271,68 90,00
EBIT-Marge5 5,42 6,05 2,41 2,39 11,64 8,16 2,89
Jahresüberschuss1 81,74 98,50 34,90 33,79 249,89 154,27 40,00
Netto-Marge6 3,24 3,83 1,34 1,22 7,34 4,64 1,29
Cashflow1,7 195,32 143,34 4,09 164,42 459,98 384,89 200,00
Ergebnis je Aktie8 3,40 4,12 1,42 1,38 10,19 7,13 2,10
Dividende8 0,13 0,40 0,13 0,13 0,13 0,13 0,13
Quelle: boersengefluester.de und Firmenangaben

  Geschäftsbericht 2021 - Kostenfrei herunterladen.  
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de

Wirtschaftsprüfer: -

INVESTOR-INFORMATIONEN
©boersengefluester.de
Drägerwerk ST
WKN Kurs in € Einschätzung Börsenwert in Mio. €
555060 44,700 Kaufen 881,57
KGV 2023e KGV 10Y-Ø BGFL-Ratio Shiller-KGV
10,64 18,18 0,58 10,13
KBV KCV KUV EV/EBITDA
0,63 2,18 0,26 2,60
Dividende '20 in € Dividende '21e in € Div.-Rendite '21e
in %
Hauptversammlung
0,13 0,13 0,29 06.05.2022
Q1-Zahlen Q2-Zahlen Q3-Zahlen Bilanz-PK
28.04.2022 28.07.2022 27.10.2022 03.03.2022
Abstand 60Tage-Linie Abstand 200Tage-Linie Performance YtD Performance 52 Wochen
5,63% -7,68% -17,38% -40,08%
    
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu Drägerwerk AG & Co. KGaA  ISIN: DE0005550602 können Sie bei DGAP abrufen


Medtech , 555060 , DRW8 , XETR:DRW8